Canada markets closed

Forte Biosciences, Inc. (FBRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
0.5879-0.0441 (-6.98%)
At close: 04:00PM EDT
0.5586 -0.03 (-4.98%)
After hours: 06:09PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 22.12M
Enterprise Value -8.32M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.77
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 1.90

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-40.61%
S&P500 52-Week Change 329.31%
52 Week High 31.0600
52 Week Low 30.3800
50-Day Moving Average 30.6984
200-Day Moving Average 30.6788

Share Statistics

Avg Vol (3 month) 326.28k
Avg Vol (10 day) 320.51k
Shares Outstanding 536.44M
Implied Shares Outstanding 637.63M
Float 822.01M
% Held by Insiders 110.91%
% Held by Institutions 156.60%
Shares Short (Apr 30, 2024) 428.78k
Short Ratio (Apr 30, 2024) 41.21
Short % of Float (Apr 30, 2024) 40.08%
Short % of Shares Outstanding (Apr 30, 2024) 40.08%
Shares Short (prior month Mar 28, 2024) 434.1k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 16, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Jun 16, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-60.81%
Return on Equity (ttm)-104.31%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-32.14M
Diluted EPS (ttm)-0.8100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)30.44M
Total Cash Per Share (mrq)0.84
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.45
Book Value Per Share (mrq)0.79

Cash Flow Statement

Operating Cash Flow (ttm)-30.17M
Levered Free Cash Flow (ttm)-18.81M